Project description
A breath of fresh air whenever and wherever it is needed
A steady flow of oxygen is paramount to the outcome of any treatment. Mask ventilation is common and, in the case of airway obstruction, tracheal intubation is an invasive alternative. Supraglottic airway devices (SADs) that can be inserted into the pharynx through the mouth are somewhere in between and have become a mainstay of emergency management. The market for improved designs allowing more widespread use is growing. The Swiss SME Singularity is addressing this demand with a universal tool that covers all the functions offered by the other SADs but is safer and less expensive. The EU-funded Safe SAD project is supporting technology optimisation and providing a roadmap for commercialisation.
Objective
Singularity AG is a medical device company created in 2012, in Zürich. The inspiration driving the company was to design an advanced unique 2nd generation Supraglottic Airway Device (SAD). The original design of “Singularity SAD” offers an innovative, versatile, cheaper and safer alternative compared to the current static SADs. It avoids unnecessary risks and complications associated to insertion, maintenance and manipulation of patients under anesthesia and can be used in most situations requiring airway management. Two different series of SAD have been developed, the SAD Air and the SAD Compact, different parts of which have been patented for diverse uses and licensed in several countries. All pieces of these devices have been specifically designed to allow for the full mechanization of production, which ensures a competitive price using cost-effective manufacturing technologies. The shareholders of Singularity AG are Mr. Werner Dubach and Mr. Fabio Hausammann, who have an extensive experience in the production of devices and have developed Singularity in cooperation with Prof. Dr. Markus Weiss, who completed the team with his medical expertise. The Singularity project has received the support of relevant companies and institutions for its development, which has motivated the current TRL 6. The “all-in-one functional design” of Singularity SADs makes it a universal tool that covers all the functions offered by the other SADs. The demand for this type of device is estimated at more than 150 million units per year. The wide range of applications and extended use under anesthesia ensure the massive and continuous use of SADs. The functionality of Singularity has been successfully tested using the SAD Air prototype in the prestigious Schulthess Klinik (Zürich), which has an experienced anesthesiology team. The unit at size 4 has been fully produced for validation in clinical tests, showing excellent results in an initial study with 10 patients.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- engineering and technology medical engineering
- medical and health sciences clinical medicine emergency medicine
- medical and health sciences clinical medicine critical care medicine
- medical and health sciences health sciences infectious diseases RNA viruses coronaviruses
- medical and health sciences clinical medicine anaesthesiology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
8124 MAUR
Switzerland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.